PNTG The Pennant Group, Inc.
Healthcare$33.92+0.00%ClosedMarket Cap: $1.18B
As of 2026-05-26
Valuation
P/E (TTM)
35.80
PEG
1.15
P/B
3.40
P/S
1.15
EV/EBITDA
24.17
DCF Value
$-8.83
FCF Yield
4.0%
Div Yield
0.0%
Margins & Returns
Gross Margin
14.8%
Operating Margin
5.7%
Net Margin
3.0%
ROE
9.2%
ROA
3.2%
ROIC
5.0%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $285.4M | 13.1% | $18.1M | $8.5M | $— | — |
| Q4 null | $289.3M | 12.9% | $18.1M | $8.6M | $— | — |
| FY null | $947.7M | 12.9% | $51.4M | $29.6M | $— | — |
| Q3 null | $229.0M | 20.2% | $10.2M | $6.1M | $— | — |
| Q2 null | $219.5M | 13.8% | $11.5M | $7.1M | $— | — |
| Q1 null | $209.8M | 14.0% | $12.7M | $7.8M | $— | — |
| Q4 null | $188.9M | 13.2% | $9.2M | $5.8M | $— | — |
| FY null | $695.2M | 13.5% | $38.1M | $22.6M | $— | — |
| Q3 null | $180.7M | 14.0% | $10.8M | $6.2M | $— | — |
| Q2 null | $168.7M | 13.6% | $9.6M | $5.7M | $— | — |
| Q1 null | $156.9M | 13.1% | $8.5M | $4.9M | $— | — |
| Q4 2023 | $146.0M | 12.8% | $7.6M | $4.3M | $0.14 | — |